R&D Partner Content 7th RNA-Targeted Drug Discovery & Development Summit Optimizing Lead Discovery, Structural Analysis & Preclinical Modeling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation
R&D Partner Content 9th CDD For Biologics Summit 2024 Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development
R&D Partner Content Targeted Radiopharmaceuticals Summit EU 2024 Taking place in Amsterdam 3rd- 5th December! With 40+ new speakers, 2 tracks of content (pre-clinical and clinical), a deep dive workshop day
R&D Partner Content R&D Procurement & Outsourcing in Biopharma West Summit An event to empower you with the knowledge and tools to excel in procurement and outsourcing
R&D Partner Content 4th Mitochondrial Dysfunction Drug Development Summit Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success
R&D Partner Content 8th Annual Complement-Based Drug Development Summit Achieving Efficacy & Exploring Indication Expansion for Complement Inhibitors
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.